Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-12-03T19:33:31.407Z Has data issue: false hasContentIssue false
  • English
  • Français

P02.227 Comparison of the coronary heart disease risk factor profile of risperidone vs olanzapine treated patients

Published online by Cambridge University Press:  16 April 2020

R.H. Bouchard ,
J. Villeneuve ,
N. Alméras ,
I. Simoneau ,
M.F. Demers ,
C. Cadrin ,
M.A. Roy ,
J.P. Mortard  and
J.P. Despres
R.H. Bouchard
Affiliation:
Polyclinique Sainte-Anne, Québec
J. Villeneuve
Affiliation:
Centre de Recherche sur les Maladies Lipidiques. Québec, Canada
N. Alméras
Affiliation:
Polyclinique Sainte-Anne, Québec
I. Simoneau
Affiliation:
Polyclinique Sainte-Anne, Québec
M.F. Demers
Affiliation:
Polyclinique Sainte-Anne, Québec
C. Cadrin
Affiliation:
Polyclinique Sainte-Anne, Québec
M.A. Roy
Affiliation:
Polyclinique Sainte-Anne, Québec
J.P. Mortard
Affiliation:
Polyclinique Sainte-Anne, Québec
J.P. Despres
Affiliation:
Polyclinique Sainte-Anne, Québec

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 15 , Issue S2: Congress of the Association of European Psychiatrists , October 2000 , pp. 382s
Copyright
Copyright © European Psychiatric Association 2000
Submit a response

Comments

No Comments have been published for this article.